Atrial fibrillation (AF) has been known to have several pathophysiologic mechanisms including
endothelial dysfunction of heart and vessel. This study was designed to determine the
efficacy of NOAC therapy in the prevention of endothelial dysfunction and progression of
atherosclerosis of AF subjects.